Chemotherapy‐driven dysbiosis in the intestinal microbiome

Chemotherapy is commonly used as myeloablative conditioning treatment to prepare patients for haematopoietic stem cell transplantation (HSCT). Chemotherapy leads to several side effects, with gastrointestinal (GI) mucositis being one of the most frequent. Current models of GI mucositis pathophysiology are generally silent on the role of the intestinal microbiome.

[1]  Gary D Bader,et al.  A travel guide to Cytoscape plugins , 2012, Nature Methods.

[2]  T. Urich,et al.  Longitudinal study of murine microbiota activity and interactions with the host during acute inflammation and recovery , 2014, The ISME Journal.

[3]  D. Relman,et al.  Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation , 2010, Proceedings of the National Academy of Sciences.

[4]  K. Saigenji,et al.  Mechanisms for cytoprotection by vitamin U from ethanol-induced gastric mucosal damage in rats , 2005, Digestive Diseases and Sciences.

[5]  M. Sandkvist.  Type II Secretion and Pathogenesis , 2001, Infection and Immunity.

[6]  P. Tak,et al.  Signal Transduction Pathways in Chronic Inflammatory Autoimmune Disease: Small GTPases , 2012, The open rheumatology journal.

[7]  Jesse R. Zaneveld,et al.  Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences , 2013, Nature Biotechnology.

[8]  James Borneman,et al.  Reprograming of gut microbiome energy metabolism by the FUT2 Crohn's disease risk polymorphism , 2014, The ISME Journal.

[9]  J. Carratalá,et al.  Bloodstream infections in neutropenic patients with cancer: differences between patients with haematological malignancies and solid tumours. , 2014, Journal of Infection.

[10]  Claus Jacob,et al.  Reactive Sulfur Species: An Emerging Concept in Oxidative Stress , 2002, Biological chemistry.

[11]  B. Wiedenmann,et al.  Probiotic carbohydrates reduce intestinal permeability and inflammation in metabolic diseases , 2009, Gut.

[12]  H. Said,et al.  Lipopolysaccharide causes an increase in intestinal tight junction permeability in vitro and in vivo by inducing enterocyte membrane expression and localization of TLR-4 and CD14. , 2013, The American journal of pathology.

[13]  E. Montassier,et al.  Systematic review: the role of the gut microbiota in chemotherapy‐ or radiation‐induced gastrointestinal mucositis – current evidence and potential clinical applications , 2014, Alimentary pharmacology & therapeutics.

[14]  William A. Walters,et al.  QIIME allows analysis of high-throughput community sequencing data , 2010, Nature Methods.

[15]  W. Tissing,et al.  The Role of Intestinal Microbiota in the Development and Severity of Chemotherapy-Induced Mucositis , 2010, PLoS pathogens.

[16]  K. Barrett,et al.  Probiotics and Commensals Reverse TNF-α– and IFN-γ–Induced Dysfunction in Human Intestinal Epithelial Cells , 2003 .

[17]  V. Smeianov,et al.  Anti‐inflammatory properties of intestinal Bifidobacterium strains isolated from healthy infants , 2012, Microbiology and immunology.

[18]  B. Melichar,et al.  The significance of altered gastrointestinal permeability in cancer patients , 2011, Current opinion in supportive and palliative care.

[19]  B. Eikmanns,et al.  Anti-inflammatory effects of bifidobacteria by inhibition of LPS-induced NF-κB activation , 2006 .

[20]  Dong-Hyun Kim,et al.  The Degradation of Glycosaminoglycans by Intestinal Microflora Deteriorates Colitis in Mice , 2009, Inflammation.

[21]  I. Lima,et al.  Intestinal Barrier Function and Secretion in Methotrexate-Induced Rat Intestinal Mucositis , 2004, Digestive Diseases and Sciences.

[22]  H. Hosseinzadeh,et al.  A study of acute and chronic anti-nociceptive and anti-inflammatory effects of thiamine in mice. , 2008, Iranian biomedical journal.

[23]  K. Hotta,et al.  Augmentative effects of L‐cysteine and methylmethionine sulfonium chloride on mucin secretion in rabbit gastric mucous cells , 2000, Journal of Gastroenterology and Hepatology.

[24]  C. Manichanh,et al.  Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach , 2005, Gut.

[25]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[26]  R. Willén,et al.  Intestinal permeability in humans is increased after radiation therapy , 2000, Diseases of the colon and rectum.

[27]  A. Cummins,et al.  Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans , 2000, Gut.

[28]  D. Breuillé,et al.  Specific amino acids increase mucin synthesis and microbiota in dextran sulfate sodium-treated rats. , 2006, The Journal of nutrition.

[29]  A. Latorre,et al.  Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals , 2014, Mucosal Immunology.

[30]  Anders F. Andersson,et al.  Comparative Analysis of Human Gut Microbiota by Barcoded Pyrosequencing , 2008, PloS one.

[31]  S. Massart,et al.  16S rRNA Gene Pyrosequencing Reveals Shift in Patient Faecal Microbiota During High-Dose Chemotherapy as Conditioning Regimen for Bone Marrow Transplantation , 2014, Microbial Ecology.

[32]  K. Barrett,et al.  Probiotics and commensals reverse TNF-alpha- and IFN-gamma-induced dysfunction in human intestinal epithelial cells. , 2006, Gastroenterology.

[33]  E. N. Bergman.  Energy contributions of volatile fatty acids from the gastrointestinal tract in various species. , 1990, Physiological reviews.

[34]  J. Clemente,et al.  Human gut microbiome viewed across age and geography , 2012, Nature.

[35]  Lena Holm,et al.  The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria , 2010, Gut microbes.

[36]  Antonio Calignano,et al.  Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. , 2011, World journal of gastroenterology.

[37]  M. Candela,et al.  Longitudinal analysis of inflammation and microbiota dynamics in a model of mild chronic dextran sulfate sodium-induced colitis in mice. , 2014, World journal of gastroenterology.

[38]  C. Bertrand,et al.  LPS-induced lung inflammation is linked to increased epithelial permeability: role of MLCK , 2005, European Respiratory Journal.

[39]  M. Ashoori,et al.  Riboflavin (vitamin B2) and oxidative stress: a review , 2014, British Journal of Nutrition.

[40]  Scott B Cantor,et al.  The burdens of cancer therapy , 2003, Cancer.

[41]  Timothy L. Tickle,et al.  Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment , 2012, Genome Biology.

[42]  J. Sirard,et al.  Bacterial flagellins: mediators of pathogenicity and host immune responses in mucosa. , 2004, Trends in microbiology.

[43]  K. Madsen,et al.  Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[44]  S. Sonis.  The pathobiology of mucositis , 2004, Nature Reviews Cancer.

[45]  J. Yabut,et al.  Glutathione depletion and oxidative stress. , 2002, Parkinsonism & related disorders.

[46]  G. Jha,et al.  Bacterial type two secretion system secreted proteins: double-edged swords for plant pathogens. , 2005, Molecular plant-microbe interactions : MPMI.

[47]  F. Russo,et al.  The effects of fluorouracil, epirubicin, and cyclophosphamide (FEC60) on the intestinal barrier function and gut peptides in breast cancer patients: an observational study , 2013, BMC Cancer.

[48]  Maria Karlsson,et al.  Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. , 2010, Cell host & microbe.

[49]  V. Verhasselt,et al.  Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: evidence for a soluble CD14-dependent pathway. , 1997, Journal of immunology.

[50]  P. Ljungman,et al.  Incidence, risk factors, and outcome of bloodstream infections during the pre‐engraftment phase in 521 allogeneic hematopoietic stem cell transplantations , 2014, Transplant infectious disease : an official journal of the Transplantation Society.

[51]  Matthew J. Gebert,et al.  Alterations in the gut microbiota associated with HIV-1 infection. , 2013, Cell host & microbe.

[52]  J. Doré,et al.  Identification of NF-κB Modulation Capabilities within Human Intestinal Commensal Bacteria , 2011, Journal of biomedicine & biotechnology.

[53]  S. Umar,et al.  Citrobacter rodentium‐induced NF‐κB activation in hyperproliferating colonic epithelia: role of p65 (Ser536) phosphorylation , 2006, British journal of pharmacology.

[54]  J. Donnelly,et al.  Citrulline: a potentially simple quantitative marker of intestinal epithelial damage following myeloablative therapy , 2004, Bone Marrow Transplantation.

[55]  S. Naik,et al.  Anti-inflammatory activity of thiamine and nicotinic acid. , 1970, Biochemical pharmacology.

[56]  Jeff F. Miller,et al.  Roles for motility in bacterial–host interactions , 1997, Molecular microbiology.

[57]  R. Knight,et al.  Supervised classification of human microbiota. , 2011, FEMS microbiology reviews.

[58]  B. Roe,et al.  A core gut microbiome in obese and lean twins , 2008, Nature.

[59]  Eoin L. Brodie,et al.  Greengenes, a Chimera-Checked 16S rRNA Gene Database and Workbench Compatible with ARB , 2006, Applied and Environmental Microbiology.

[60]  K. Rolston.  The burdens of cancer therapy , 2004, Cancer.

[61]  Curtis Huttenhower,et al.  Gut microbiome composition and function in experimental colitis during active disease and treatment-induced remission , 2014, The ISME Journal.

[62]  B. Finlay,et al.  Muc2 Protects against Lethal Infectious Colitis by Disassociating Pathogenic and Commensal Bacteria from the Colonic Mucosa , 2010, PLoS pathogens.

[63]  D. Sinderen,et al.  Gut microbiota composition correlates with diet and health in the elderly , 2012, Nature.

[64]  Se Jin Song,et al.  The treatment-naive microbiome in new-onset Crohn's disease. , 2014, Cell host & microbe.

[65]  Rob Knight,et al.  Advancing the Microbiome Research Community , 2014, Cell.

[66]  L. Price,et al.  Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality , 2006, Bone Marrow Transplantation.

[67]  J. Bouma,et al.  Regulation of the intestinal mucin MUC2 expression by short chain fatty acids: implications for epithelial protection , 2009, The Biochemical journal.

[68]  J. Armitage,et al.  High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[69]  W. Tissing,et al.  Substantial decreases in the number and diversity of microbiota during chemotherapy-induced gastrointestinal mucositis in a rat model , 2015, Supportive Care in Cancer.

[70]  J. Galmiche,et al.  Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease. , 2000, Gut.

[71]  M. Lyte,et al.  Stress at the intestinal surface: catecholamines and mucosa–bacteria interactions , 2010, Cell and Tissue Research.

[72]  G. Papanicolaou,et al.  Pre‐ and post‐engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients , 2005, Transplant infectious disease : an official journal of the Transplantation Society.

[73]  C. Viscoli,et al.  Enterococcal bloodstream infection after hematopoietic stem cell transplant: experience of a center with a low prevalence of vancomycin-resistant enterococci. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[74]  E. Batard,et al.  Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance , 2013, European Journal of Clinical Microbiology & Infectious Diseases.

[75]  P. Freestone,et al.  Influence of dietary catechols on the growth of enteropathogenic bacteria. , 2007, International journal of food microbiology.